← Back to Clinical Trials
Recruiting NCT06655402

NCT06655402 Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06655402
Status Recruiting
Phase
Sponsor Emory University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 220 participants
Start Date 2025-03-25
Primary Completion 2029-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CARE-CITEAttention Control GroupActigraph GT3X+

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 220 participants in total. It began in 2025-03-25 with a primary completion date of 2029-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Stroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, web-based care partner-focused intervention (CARE-CITE) designed to foster problem-solving and skill building while facilitating care partner engagement during stroke survivor (SS) upper extremity practice of daily activities in the home setting. By providing a family-focused approach to rehabilitation interventions, this project will help develop more effective treatments that improve CP and outcomes after stroke.

Eligibility Criteria

CarePartners (CP): Inclusion Criteria: * Must be at least18 years old, * Able to read and write English, * Mini-mental test score greater than 24 * Individuals who are a spouse/partner or family member dwelling in the same household and self-identify as the primary caregiver of the SS. Stroke Survivors (SS): Inclusion Criteria: * Must be at least18 years old * More than 3 months and less than 2yrs post-ischemic or hemorrhagic event * Discharged home from the hospital with minimal to moderate UE deficits (can actively initiate 20 degrees of wrist and 10 degrees of finger extension) * Mini-mental test greater than 24 * No physician determined medical problems that would limit participation, * Must have CP living in the home Exclusion Criteria for CP and SS: * Significant cognitive deficits

Contact & Investigator

Central Contact

Sarah R Blanton, PT, DPT

✉ sblanto@emory.edu

📞 (404) 712-2222

Principal Investigator

Sarah Blanton, PT, DPT

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT06655402 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06655402 currently recruiting?

Yes, NCT06655402 is actively recruiting participants. Contact the research team at sblanto@emory.edu for enrollment information.

Where is the NCT06655402 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT06655402 clinical trial?

NCT06655402 is sponsored by Emory University. The principal investigator is Sarah Blanton, PT, DPT at Emory University. The trial plans to enroll 220 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology